VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q57161824 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241120235757.0
008 241120nneanz||abbn n and d
035 ‎‡a (WKP)Q57161824‏
024 ‎‡a 0000-0002-1923-462X‏ ‎‡2 orcid‏
024 ‎‡a 7406552825‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q57161824‏
100 0 ‎‡a David Williams‏ ‎‡9 nl‏ ‎‡9 es‏ ‎‡9 ast‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a ডেভিড উইলিয়ামস‏ ‎‡9 bn‏
400 0 ‎‡a David Williams‏ ‎‡c Neurologist‏ ‎‡9 en‏
670 ‎‡a Author's A comparison of computerised strain gauge plethysmography with D-dimer testing in screening for deep-vein thrombosis‏
670 ‎‡a Author's A novel and essential role for FcγRIIa in cancer cell-induced platelet activation.‏
670 ‎‡a Author's A population-based study of dosing and persistence with anti-dementia medications.‏
670 ‎‡a Author's A randomized controlled trial of platelet activity before and after cessation of clopidogrel therapy in patients with stable cardiovascular disease.‏
670 ‎‡a Author's A systematic review of the clinical effectiveness of emergency endovascular therapy using mechanical thrombectomy in acute ischaemic stroke: implications for service delivery‏
670 ‎‡a Author's Access to Rehabilitation at Six Months Post Stroke: A Profile from the Action on Secondary Prevention Interventions and Rehabilitation in Stroke (ASPIRE-S) Study.‏
670 ‎‡a Author's Acute hospital, community, and indirect costs of stroke associated with atrial fibrillation: population-based study.‏
670 ‎‡a Author's Addressing potentially inappropriate prescribing in older patients: development and pilot study of an intervention in primary care (the OPTI-SCRIPT study)‏
670 ‎‡a Author's Adverse-drug-reaction related admissions to a hospital in Scotland‏
670 ‎‡a Author's Adverse drug reactions as a cause of admission to a Dublin-based university teaching hospital.‏
670 ‎‡a Author's Adverse Drug reactions in an Ageing PopulaTion‏
670 ‎‡a Author's Adverse Drug reactions in an Ageing PopulaTion (ADAPT) study protocol: a cross-sectional and prospective cohort study of hospital admissions related to adverse drug reactions in older patients‏
670 ‎‡a Author's Adverse events in healthcare: learning from mistakes.‏
670 ‎‡a Author's Analysis of Workflow and Time to Treatment on Thrombectomy Outcome in the Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) Randomized, Controlled Trial.‏
670 ‎‡a Author's Anticholinergic and sedative drug burden in community-dwelling older people: a national database study‏
670 ‎‡a Author's Are different groups of patients with stroke more likely to be excluded from the new UK general medical services contract? A cross-sectional retrospective analysis of a large primary care population‏
670 ‎‡a Author's Aspirin failure in patients presenting with acute cerebrovascular ischaemia‏
670 ‎‡a Author's Can a media campaign change health service use in a population with stroke symptoms? Examination of the first Irish stroke awareness campaign‏
670 ‎‡a Author's Changing Management of Acute Ischaemic Stroke: the New Treatments and Emerging Role of Endovascular Therapy.‏
670 ‎‡a Author's Cognitive impairment and cardiovascular medication use: Results from Wave 1 of The Irish Longitudinal Study on Ageing‏
670 ‎‡a Author's Cognitive Impairment, Vulnerability, and Mortality Post Ischemic Stroke: A Five-Year Follow-Up of the Action on Secondary Prevention Interventions and Rehabilitation in Stroke (ASPIRE-S) Cohort‏
670 ‎‡a Author's Commentary on hormonal contraceptive use in Ireland: trends and co-prescribing practices‏
670 ‎‡a Author's Constitutional symptoms at the onset of rheumatoid arthritis and subsequent arterial stiffness.‏
670 ‎‡a Author's Cough Suppressant and Fluoxetine in the Treatment of Pseudobulbar Affect: A Case Report‏
670 ‎‡a Author's Defining the Role of the Stroke Physician During Endovascular Therapy of Acute Ischemic Stroke‏
670 ‎‡a Author's Doctors' handovers in hospitals: a literature review‏
670 ‎‡a Author's Does cognitive impairment impact adherence? A systematic review and meta-analysis of the association between cognitive impairment and medication non-adherence in stroke‏
670 ‎‡a Author's Does the use of statins compromise the effectiveness of platelet inhibition by clopidogrel?‏
670 ‎‡a Author's Early Trajectory of Stroke Severity Predicts Long-Term Functional Outcomes in Ischemic Stroke Subjects: Results From the ESCAPE Trial (Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion With Emphasis on Minimizing CT t‏
670 ‎‡a Author's Effect of the UK incentive-based contract on the management of patients with stroke in primary care‏
670 ‎‡a Author's Effectiveness of medicines review with web-based pharmaceutical treatment algorithms in reducing potentially inappropriate prescribing in older people in primary care: a cluster randomized trial (OPTI-SCRIPT study protocol).‏
670 ‎‡a Author's Endovascular thrombectomy beyond 12 hours of stroke onset: a stroke network's experience of late intervention.‏
670 ‎‡a Author's Endovascular treatment for acute ischaemic stroke with large vessel occlusion: the experience of a regional stroke service.‏
670 ‎‡a Author's Evidence for age and sex differences in the secondary prevention of stroke in Scottish primary care.‏
670 ‎‡a Author's Evidence for inequalities in the management of coronary heart disease in Scotland.‏
670 ‎‡a Author's Evidence for prolonged prescribing of aspirin-clopidogrel combination in Scottish primary care‏
670 ‎‡a Author's Gender differences in the extent and timing of the reflected arterial waveform in the presence of coronary artery disease.‏
670 ‎‡a Author's Impact of the pay-for-performance contract and the management of hypertension in Scottish primary care: a 6-year population-based repeated cross-sectional study‏
670 ‎‡a Author's Implications of stroke for caregiver outcomes: findings from the ASPIRE-S study.‏
670 ‎‡a Author's Improved late survival and disability after stroke with therapeutic anticoagulation for atrial fibrillation: a population study.‏
670 ‎‡a Author's Indices of cardiovascular function derived from peripheral pulse wave analysis using radial applanation tonometry: a measurement repeatability study‏
670 ‎‡a Author's Influence of material deprivation on prescribing patterns within a deprived population.‏
670 ‎‡a Author's Influence of media and regulatory changes on prescribing of cotrimoxazole and trimethoprim in Ireland‏
670 ‎‡a Author's Initial uptake and evidence of safe prescribing practice with Buproprion (Zyban).‏
670 ‎‡a Author's Interarm blood pressure difference in a post-stroke population.‏
670 ‎‡a Author's Intra-Arterial Therapy and Post-Treatment Infarct Volumes: Insights From the ESCAPE Randomized Controlled Trial.‏
670 ‎‡a Author's Intracerebral haemorrhage and hemiplegia with heterotopic ossification of the affected hip.‏
670 ‎‡a Author's Managing cognitive impairment following stroke: protocol for a systematic review of non-randomised controlled studies of psychological interventions‏
670 ‎‡a Author's Medication incidents reported to an online incident reporting system.‏
670 ‎‡a Author's Monitoring medicines use: the role of the clinical pharmacologist‏
670 ‎‡a Author's Moyamoya disease and moyamoya syndrome in Ireland: patient demographics, mode of presentation and outcomes of EC-IC bypass surgery‏
670 ‎‡a Author's New insights about vitamin D and cardiovascular disease: a narrative review‏
670 ‎‡a Author's Nonequivalence of inhaled and nebulized salbutamol in the assessment of endothelial dysfunction.‏
670 ‎‡a Author's Osteoporosis, obesity, and sarcopenia on abdominal CT: a review of epidemiology, diagnostic criteria, and management strategies for the reporting radiologist‏
670 ‎‡a Author's Outcomes of endovascular treatment for acute large-vessel ischaemic stroke more than 6 h after symptom onset.‏
670 ‎‡a Author's Patient behaviour at the time of stroke onset: a cross-sectional survey of patient response to stroke symptoms‏
670 ‎‡a Author's Patient safety: helping medical students understand error in healthcare.‏
670 ‎‡a Author's Pharmacoepidemiology--an Irish perspective‏
670 ‎‡a Author's Poor return of functional mobility after hip fracture in older patients-it's time to improve on hip fracture prevention‏
670 ‎‡a Author's Potentially inappropriate prescribing in two populations with differing socio-economic profiles: a cross-sectional database study using the PROMPT criteria‏
670 ‎‡a Author's Preparedness of newly qualified doctors in Ireland for prescribing in clinical practice.‏
670 ‎‡a Author's Prescribing of antidiabetic therapies in Ireland: 10-year trends 2003-2012.‏
670 ‎‡a Author's Prescription quality in an acute medical ward‏
670 ‎‡a Author's Rates and Determinants of 5-Year Outcomes After Atrial Fibrillation-Related Stroke: A Population Study.‏
670 ‎‡a Author's Rates, Predictors, and Outcomes of Early and Late Recurrence After Stroke: The North Dublin Population Stroke Study.‏
670 ‎‡a Author's Relationship between arterial dysfunction and extra-articular features in patients with rheumatoid arthritis.‏
670 ‎‡a Author's Relationship between arterial stiffness and Stanford Health Assessment Questionnaire disability in rheumatoid arthritis patients without overt arterial disease.‏
670 ‎‡a Author's Renal dysfunction and chronic kidney disease in ischemic stroke and transient ischemic attack: A population-based study.‏
670 ‎‡a Author's Repeatability of central aortic blood pressures measured non-invasively using radial artery applanation tonometry and peripheral pulse wave analysis.‏
670 ‎‡a Author's Repeatability of the measurement of aortic pulse wave velocity (aPWV) in the clinical assessment of arterial stiffness in community-dwelling older patients using the Vicorder(®) device‏
670 ‎‡a Author's Repeatability of the measurement of augmentation index in the clinical assessment of arterial stiffness using radial applanation tonometry.‏
670 ‎‡a Author's Safety of drugs used in the treatment of osteoporosis.‏
670 ‎‡a Author's Secondary prevention after ischaemic stroke: the ASPIRE-S study‏
670 ‎‡a Author's Secondary prevention and cognitive function after stroke: a study protocol for a 5-year follow-up of the ASPIRE-S cohort‏
670 ‎‡a Author's Secondary resistance to tolvaptan in two patients with SIAD due to small cell lung cancer‏
670 ‎‡a Author's Smoking cessation in pregnancy‏
670 ‎‡a Author's Stroke recurrence within the time window recommended for carotid endarterectomy.‏
670 ‎‡a Author's Stroke rehabilitation: recent advances and future therapies‏
670 ‎‡a Author's STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease‏
670 ‎‡a Author's Suboptimal lipid management before and after ischaemic stroke and TIA-the North Dublin Population Stroke Study.‏
670 ‎‡a Author's The development of the PROMPT‏
670 ‎‡a Author's The development of the PROMPT (PRescribing Optimally in Middle-aged People's Treatments) criteria‏
670 ‎‡a Author's The effect of the UK incentive-based contract on the management of patients with coronary heart disease in primary care‏
670 ‎‡a Author's The effect of vitamin D supplementation on arterial stiffness in an elderly community-based population‏
670 ‎‡a Author's The epidemiology and type of medication errors reported to the National Poisons Information Centre of Ireland‏
670 ‎‡a Author's The experience of recurrent fallers in the first year after stroke‏
670 ‎‡a Author's The future of endovascular treatment: Insights from the ESCAPE investigators‏
670 ‎‡a Author's The great ESCAPE - a clinical pharmacologist's journey in stroke research.‏
670 ‎‡a Author's The Irish National Adverse Events Study‏
670 ‎‡a Author's The Irish National Adverse Events Study (INAES): the frequency and nature of adverse events in Irish hospitals-a retrospective record review study.‏
670 ‎‡a Author's The prevalence of a raised aldosterone-renin ratio‏
670 ‎‡a Author's The prevalence of a raised aldosterone-renin ratio (ARR) among new referrals to a hypertension clinic‏
670 ‎‡a Author's The UK's NHS and pharma: need for more clinical pharmacologists‏
670 ‎‡a Author's Time for a Time Window Extension: Insights from Late Presenters in the ESCAPE Trial‏
670 ‎‡a Author's Timing of aspirin and secondary preventative therapies in acute stroke: support for use of stroke units‏
670 ‎‡a Author's Under-prescribing of cardiovascular therapies for diabetes in primary care‏
670 ‎‡a Author's Underreporting of adverse drug reactions: attitudes of Irish doctors‏
670 ‎‡a Author's Use of pulse wave analysis to measure arterial stiffness in old age‏
670 ‎‡a Author's Use of the augmentation index to predict short-term outcome after acute ischemic stroke.‏
670 ‎‡a Author's Validation of two risk-prediction models for recurrent falls in the first year after stroke: a prospective cohort study.‏
670 ‎‡a Author's Value of CT angiography in anterior circulation large vessel occlusive stroke: Imaging findings, pearls, and pitfalls.‏
670 ‎‡a Author's ‘What effect do safety culture interventions have on health care workers in hospital settings?’ A systematic review of the international literature‏
670 ‎‡a Author's White matter lesions and endothelial dysfunction measured by pulse wave analysis.‏
670 ‎‡a Author's Why do transient ischemic attack patients have higher early stroke recurrence risk than those with ischemic stroke? Influence of patient behavior and other risk factors in the North Dublin Population Stroke Study.‏
909 ‎‡a (scopus) 7406552825‏ ‎‡9 1‏
909 ‎‡a (orcid) 000000021923462x‏ ‎‡9 1‏
919 ‎‡a moyamoyadiseaseandmoyamoyasyndromeinirelandpatientdemographicsmodeofpresentationandoutcomesofecicbypasssurgery‏ ‎‡A Moyamoya disease and moyamoya syndrome in Ireland: patient demographics, mode of presentation and outcomes of EC-IC bypass surgery‏ ‎‡9 1‏
919 ‎‡a irishnationaladverseeventsstudy‏ ‎‡A The Irish National Adverse Events Study‏ ‎‡9 1‏
919 ‎‡a monitoringmedicinesusetheroleoftheclinic Alpha rmacologist‏ ‎‡A Monitoring medicines use: the role of the clinical pharmacologist‏ ‎‡9 1‏
919 ‎‡a medicationincidentsreportedtoanonlineincidentreportingsystem‏ ‎‡A Medication incidents reported to an online incident reporting system.‏ ‎‡9 1‏
919 ‎‡a irishnationaladverseeventsstudyinaesthefrequencyandnatureofadverseeventsinirishhospitalsaretrospectiverecordreviewstudy‏ ‎‡A The Irish National Adverse Events Study (INAES): the frequency and nature of adverse events in Irish hospitals-a retrospective record review study.‏ ‎‡9 1‏
919 ‎‡a managingcognitiveimpairmentfollowingstrokeprotocolforasystematicreviewofnonrandomisedcontrolledstudiesofpsychologicalinterventions‏ ‎‡A Managing cognitive impairment following stroke: protocol for a systematic review of non-randomised controlled studies of psychological interventions‏ ‎‡9 1‏
919 ‎‡a intracerebralhaemorrhageandhemiplegiawithheterotopicossificationoftheaffectedhip‏ ‎‡A Intracerebral haemorrhage and hemiplegia with heterotopic ossification of the affected hip.‏ ‎‡9 1‏
919 ‎‡a prevalenceofaraisedaldosteronereninratio‏ ‎‡A The prevalence of a raised aldosterone-renin ratio‏ ‎‡9 1‏
919 ‎‡a intraarterialtherapyandposttreatmentinfarctvolumesinsightsfromtheescaperandomizedcontrolledtrial‏ ‎‡A Intra-Arterial Therapy and Post-Treatment Infarct Volumes: Insights From the ESCAPE Randomized Controlled Trial.‏ ‎‡9 1‏
919 ‎‡a interarmbloodpressuredifferenceinapoststrokepopulation‏ ‎‡A Interarm blood pressure difference in a post-stroke population.‏ ‎‡9 1‏
919 ‎‡a prevalenceofaraisedaldosteronereninratioarramongnewreferralstoahypertensionclinic‏ ‎‡A The prevalence of a raised aldosterone-renin ratio (ARR) among new referrals to a hypertension clinic‏ ‎‡9 1‏
919 ‎‡a initialuptakeandevidenceofsafeprescribingpracticewithbuproprionzyban‏ ‎‡A Initial uptake and evidence of safe prescribing practice with Buproprion (Zyban).‏ ‎‡9 1‏
919 ‎‡a influenceofmediaandregulatorychangesonprescribingofcotrimoxazoleandtrimethopriminireland‏ ‎‡A Influence of media and regulatory changes on prescribing of cotrimoxazole and trimethoprim in Ireland‏ ‎‡9 1‏
919 ‎‡a influenceofmaterialdeprivationonprescribingpatternswithinadeprivedpopulation‏ ‎‡A Influence of material deprivation on prescribing patterns within a deprived population.‏ ‎‡9 1‏
919 ‎‡a uksnhsandpharmaneedformoreclinic Alpha rmacologists‏ ‎‡A The UK's NHS and pharma: need for more clinical pharmacologists‏ ‎‡9 1‏
919 ‎‡a timeforatimewindowextensioninsightsfromlatepresentersintheescapetrial‏ ‎‡A Time for a Time Window Extension: Insights from Late Presenters in the ESCAPE Trial‏ ‎‡9 1‏
919 ‎‡a timingofaspirinandsecondarypreventativetherapiesinacutestrokesupportforuseofstrokeunits‏ ‎‡A Timing of aspirin and secondary preventative therapies in acute stroke: support for use of stroke units‏ ‎‡9 1‏
919 ‎‡a indicesofcardiovascularfunctionderivedfromperipheralpulsewaveanalysisusingradialapplanationtonometryameasurementrepeatabilitystudy‏ ‎‡A Indices of cardiovascular function derived from peripheral pulse wave analysis using radial applanation tonometry: a measurement repeatability study‏ ‎‡9 1‏
919 ‎‡a improvedlatesurvivalanddisabilityafterstrokewiththerapeuticanticoagulationforatrialfibrillationapopulationstudy‏ ‎‡A Improved late survival and disability after stroke with therapeutic anticoagulation for atrial fibrillation: a population study.‏ ‎‡9 1‏
919 ‎‡a implicationsofstrokeforcaregiveroutcomesfindingsfromtheaspiresstudy‏ ‎‡A Implications of stroke for caregiver outcomes: findings from the ASPIRE-S study.‏ ‎‡9 1‏
919 ‎‡a underprescribingofcardiovasculartherapiesfordiabetesinprimarycare‏ ‎‡A Under-prescribing of cardiovascular therapies for diabetes in primary care‏ ‎‡9 1‏
919 ‎‡a impactofthepayforperformancecontractandthemanagementofhypertensioninscottishprimarycarea6yearpopulationbasedrepeatedcrosssectionalstudy‏ ‎‡A Impact of the pay-for-performance contract and the management of hypertension in Scottish primary care: a 6-year population-based repeated cross-sectional study‏ ‎‡9 1‏
919 ‎‡a genderdifferencesintheextentandtimingofthereflectedarterialwaveforminthepresenceofcoronaryarterydisease‏ ‎‡A Gender differences in the extent and timing of the reflected arterial waveform in the presence of coronary artery disease.‏ ‎‡9 1‏
919 ‎‡a evidenceforprolongedprescribingofaspirinclopidogrelcombinationinscottishprimarycare‏ ‎‡A Evidence for prolonged prescribing of aspirin-clopidogrel combination in Scottish primary care‏ ‎‡9 1‏
919 ‎‡a evidenceforinequalitiesinthemanagementofcoronaryheartdiseaseinscotland‏ ‎‡A Evidence for inequalities in the management of coronary heart disease in Scotland.‏ ‎‡9 1‏
919 ‎‡a evidenceforageandsexdifferencesinthesecondarypreventionofstrokeinscottishprimarycare‏ ‎‡A Evidence for age and sex differences in the secondary prevention of stroke in Scottish primary care.‏ ‎‡9 1‏
919 ‎‡a endovasculartreatmentforacuteischaemicstrokewithlargevesselocclusiontheexperienceofaregionalstrokeservice‏ ‎‡A Endovascular treatment for acute ischaemic stroke with large vessel occlusion: the experience of a regional stroke service.‏ ‎‡9 1‏
919 ‎‡a endovascularthrombectomybeyond12hoursofstrokeonsetastrokenetworksexperienceoflateintervention‏ ‎‡A Endovascular thrombectomy beyond 12 hours of stroke onset: a stroke network's experience of late intervention.‏ ‎‡9 1‏
919 ‎‡a effectivenessofmedicinesreviewwithwebbasedpharmaceuticaltreatmentalgorithmsinreducingpotentiallyinappropriateprescribinginolderpeopleinprimarycareaclusterrandomizedtrialoptiscriptstudyprotocol‏ ‎‡A Effectiveness of medicines review with web-based pharmaceutical treatment algorithms in reducing potentially inappropriate prescribing in older people in primary care: a cluster randomized trial (OPTI-SCRIPT study protocol).‏ ‎‡9 1‏
919 ‎‡a effectoftheukincentivebasedcontractonthemanagementofpatientswithstrokeinprimarycare‏ ‎‡A Effect of the UK incentive-based contract on the management of patients with stroke in primary care‏ ‎‡9 1‏
919 ‎‡a earlytrajectoryofstrokeseveritypredictslongtermfunctionaloutcomesinischemicstrokesubjectsresultsfromtheescapetrialendovasculartreatmentforsmallcoreandanteriorcirculationproximalocclusionwithemphasisonminimizingctt‏ ‎‡A Early Trajectory of Stroke Severity Predicts Long-Term Functional Outcomes in Ischemic Stroke Subjects: Results From the ESCAPE Trial (Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion With Emphasis on Minimizing CT t‏ ‎‡9 1‏
919 ‎‡a doestheuseofstatinscompromisetheeffectivenessofplateletinhibitionbyclopidogrel‏ ‎‡A Does the use of statins compromise the effectiveness of platelet inhibition by clopidogrel?‏ ‎‡9 1‏
919 ‎‡a doescognitiveimpairmentimpactadherenceasystematicreviewandmetaanalysisoftheassociationbetweencognitiveimpairmentandmedicationnonadherenceinstroke‏ ‎‡A Does cognitive impairment impact adherence? A systematic review and meta-analysis of the association between cognitive impairment and medication non-adherence in stroke‏ ‎‡9 1‏
919 ‎‡a doctorshandoversinhospitalsaliteraturereview‏ ‎‡A Doctors' handovers in hospitals: a literature review‏ ‎‡9 1‏
919 ‎‡a definingtheroleofthestrokephysicianduringendovasculartherapyofacuteischemicstroke‏ ‎‡A Defining the Role of the Stroke Physician During Endovascular Therapy of Acute Ischemic Stroke‏ ‎‡9 1‏
919 ‎‡a coughsuppressantandfluoxetineinthetreatmentofpseudobulbaraffectacasereport‏ ‎‡A Cough Suppressant and Fluoxetine in the Treatment of Pseudobulbar Affect: A Case Report‏ ‎‡9 1‏
919 ‎‡a constitutionalsymptomsattheonsetofrheumatoidarthritisandsubsequentarterialstiffness‏ ‎‡A Constitutional symptoms at the onset of rheumatoid arthritis and subsequent arterial stiffness.‏ ‎‡9 1‏
919 ‎‡a commentaryonhormonalcontraceptiveuseinirelandtrendsandcoprescribingpractices‏ ‎‡A Commentary on hormonal contraceptive use in Ireland: trends and co-prescribing practices‏ ‎‡9 1‏
919 ‎‡a cognitiveimpairmentvulnerabilityandmortalitypostischemicstrokea5yearfollowupoftheactiononsecondarypreventioninterventionsandrehabilitationinstrokeaspirescohort‏ ‎‡A Cognitive Impairment, Vulnerability, and Mortality Post Ischemic Stroke: A Five-Year Follow-Up of the Action on Secondary Prevention Interventions and Rehabilitation in Stroke (ASPIRE-S) Cohort‏ ‎‡9 1‏
919 ‎‡a cognitiveimpairmentandcardiovascularmedicationuseresultsfromwave1oftheirishlongitudinalstudyonageing‏ ‎‡A Cognitive impairment and cardiovascular medication use: Results from Wave 1 of The Irish Longitudinal Study on Ageing‏ ‎‡9 1‏
919 ‎‡a changingmanagementofacuteischaemicstrokethenewtreatmentsandemergingroleofendovasculartherapy‏ ‎‡A Changing Management of Acute Ischaemic Stroke: the New Treatments and Emerging Role of Endovascular Therapy.‏ ‎‡9 1‏
919 ‎‡a canamediacampaignchangehealthserviceuseinapopulationwithstrokesymptomsexaminationofthe1irishstrokeawarenesscampaign‏ ‎‡A Can a media campaign change health service use in a population with stroke symptoms? Examination of the first Irish stroke awareness campaign‏ ‎‡9 1‏
919 ‎‡a aspirinfailureinpatientspresentingwithacutecerebrovascularischaemia‏ ‎‡A Aspirin failure in patients presenting with acute cerebrovascular ischaemia‏ ‎‡9 1‏
919 ‎‡a underreportingofadversedrugreactionsattitudesofirishdoctors‏ ‎‡A Underreporting of adverse drug reactions: attitudes of Irish doctors‏ ‎‡9 1‏
919 ‎‡a useofpulsewaveanalysistomeasurearterialstiffnessinoldage‏ ‎‡A Use of pulse wave analysis to measure arterial stiffness in old age‏ ‎‡9 1‏
919 ‎‡a useoftheaugmentationindextopredictshorttermoutcomeafteracuteischemicstroke‏ ‎‡A Use of the augmentation index to predict short-term outcome after acute ischemic stroke.‏ ‎‡9 1‏
919 ‎‡a validationof2riskpredictionmodelsforrecurrentfallsinthe1yearafterstrokeaprospectivecohortstudy‏ ‎‡A Validation of two risk-prediction models for recurrent falls in the first year after stroke: a prospective cohort study.‏ ‎‡9 1‏
919 ‎‡a aredifferentgroupsofpatientswithstrokemorelikelytobeexcludedfromthenewukgeneralmedicalservicescontractacrosssectionalretrospectiveanalysisofalargeprimarycarepopulation‏ ‎‡A Are different groups of patients with stroke more likely to be excluded from the new UK general medical services contract? A cross-sectional retrospective analysis of a large primary care population‏ ‎‡9 1‏
919 ‎‡a valueofctangiographyinanteriorcirculationlargevesselocclusivestrokeimagingfindingspearlsandpitfalls‏ ‎‡A Value of CT angiography in anterior circulation large vessel occlusive stroke: Imaging findings, pearls, and pitfalls.‏ ‎‡9 1‏
919 ‎‡a whateffectdosafetycultureinterventionshaveonhealthcareworkersinhospitalsettingsasystematicreviewoftheinternationalliterature‏ ‎‡A ‘What effect do safety culture interventions have on health care workers in hospital settings?’ A systematic review of the international literature‏ ‎‡9 1‏
919 ‎‡a whitematterlesionsandendothelialdysfunctionmeasuredbypulsewaveanalysis‏ ‎‡A White matter lesions and endothelial dysfunction measured by pulse wave analysis.‏ ‎‡9 1‏
919 ‎‡a anticholinergicandsedativedrugburdenincommunitydwellingolderpeopleanationaldatabasestudy‏ ‎‡A Anticholinergic and sedative drug burden in community-dwelling older people: a national database study‏ ‎‡9 1‏
919 ‎‡a whydotransientischemicattackpatientshavehigherearlystrokerecurrenceriskthanthosewithischemicstrokeinfluenceofpatientbehaviorandotherriskfactorsinthenorthdublinpopulationstrokestudy‏ ‎‡A Why do transient ischemic attack patients have higher early stroke recurrence risk than those with ischemic stroke? Influence of patient behavior and other risk factors in the North Dublin Population Stroke Study.‏ ‎‡9 1‏
919 ‎‡a analysisofworkflowandtimetotreatmentonthrombectomyoutcomeintheendovasculartreatmentforsmallcoreandproximalocclusionischemicstrokeescaperandomizedcontrolledtrial‏ ‎‡A Analysis of Workflow and Time to Treatment on Thrombectomy Outcome in the Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) Randomized, Controlled Trial.‏ ‎‡9 1‏
919 ‎‡a adverseeventsinhealthcarelearningfrommistakes‏ ‎‡A Adverse events in healthcare: learning from mistakes.‏ ‎‡9 1‏
919 ‎‡a adversedrugreactionsinanageingpopulationadaptstudyprotocolacrosssectionalandprospectivecohortstudyofhospitaladmissionsrelatedtoadversedrugreactionsinolderpatients‏ ‎‡A Adverse Drug reactions in an Ageing PopulaTion (ADAPT) study protocol: a cross-sectional and prospective cohort study of hospital admissions related to adverse drug reactions in older patients‏ ‎‡9 1‏
919 ‎‡a adversedrugreactionsinanageingpopulation‏ ‎‡A Adverse Drug reactions in an Ageing PopulaTion‏ ‎‡9 1‏
919 ‎‡a adversedrugreactionsasacauseofadmissiontoadublinbaseduniversityteachinghospital‏ ‎‡A Adverse drug reactions as a cause of admission to a Dublin-based university teaching hospital.‏ ‎‡9 1‏
919 ‎‡a adversedrugreactionrelatedadmissionstoahospitalinscotland‏ ‎‡A Adverse-drug-reaction related admissions to a hospital in Scotland‏ ‎‡9 1‏
919 ‎‡a addressingpotentiallyinappropriateprescribinginolderpatientsdevelopmentandpilotstudyofaninterventioninprimarycaretheoptiscriptstudy‏ ‎‡A Addressing potentially inappropriate prescribing in older patients: development and pilot study of an intervention in primary care (the OPTI-SCRIPT study)‏ ‎‡9 1‏
919 ‎‡a acutehospitalcommunityandindirectcostsofstrokeassociatedwithatrialfibrillationpopulationbasedstudy‏ ‎‡A Acute hospital, community, and indirect costs of stroke associated with atrial fibrillation: population-based study.‏ ‎‡9 1‏
919 ‎‡a accesstorehabilitationat6monthspoststrokeaprofilefromtheactiononsecondarypreventioninterventionsandrehabilitationinstrokeaspiresstudy‏ ‎‡A Access to Rehabilitation at Six Months Post Stroke: A Profile from the Action on Secondary Prevention Interventions and Rehabilitation in Stroke (ASPIRE-S) Study.‏ ‎‡9 1‏
919 ‎‡a systematicreviewoftheclinicaleffectivenessofemergencyendovasculartherapyusingmechanicalthrombectomyinacuteischaemicstrokeimplicationsforservicedelivery‏ ‎‡A A systematic review of the clinical effectiveness of emergency endovascular therapy using mechanical thrombectomy in acute ischaemic stroke: implications for service delivery‏ ‎‡9 1‏
919 ‎‡a randomizedcontrolledtrialofplateletactivitybeforeandaftercessationofclopidogreltherapyinpatientswithstablecardiovasculardisease‏ ‎‡A A randomized controlled trial of platelet activity before and after cessation of clopidogrel therapy in patients with stable cardiovascular disease.‏ ‎‡9 1‏
919 ‎‡a populationbasedstudyofdosingandpersistencewithantidementiamedications‏ ‎‡A A population-based study of dosing and persistence with anti-dementia medications.‏ ‎‡9 1‏
919 ‎‡a novelandessentialroleforfcγriiaincancercellinducedplateletactivation‏ ‎‡A A novel and essential role for FcγRIIa in cancer cell-induced platelet activation.‏ ‎‡9 1‏
919 ‎‡a comparisonofcomputerisedstraingaugeplethysmographywith500dimertestinginscreeningfordeepveinthrombosis‏ ‎‡A A comparison of computerised strain gauge plethysmography with D-dimer testing in screening for deep-vein thrombosis‏ ‎‡9 1‏
919 ‎‡a patientsafetyhelpingmedicalstudentsunderstanderrorinhealthcare‏ ‎‡A Patient safety: helping medical students understand error in healthcare.‏ ‎‡9 1‏
919 ‎‡a repeatabilityofcentralaorticbloodpressuresmeasurednoninvasivelyusingradialarteryapplanationtonometryandperipheralpulsewaveanalysis‏ ‎‡A Repeatability of central aortic blood pressures measured non-invasively using radial artery applanation tonometry and peripheral pulse wave analysis.‏ ‎‡9 1‏
919 ‎‡a repeatabilityofthemeasurementofaorticpulsewavevelocityapwvintheclinicalassessmentofarterialstiffnessincommunitydwellingolderpatientsusingthevicorderdevice‏ ‎‡A Repeatability of the measurement of aortic pulse wave velocity (aPWV) in the clinical assessment of arterial stiffness in community-dwelling older patients using the Vicorder(®) device‏ ‎‡9 1‏
919 ‎‡a repeatabilityofthemeasurementofaugmentationindexintheclinicalassessmentofarterialstiffnessusingradialapplanationtonometry‏ ‎‡A Repeatability of the measurement of augmentation index in the clinical assessment of arterial stiffness using radial applanation tonometry.‏ ‎‡9 1‏
919 ‎‡a safetyofdrugsusedinthetreatmentofosteoporosis‏ ‎‡A Safety of drugs used in the treatment of osteoporosis.‏ ‎‡9 1‏
919 ‎‡a secondarypreventionafterischaemicstroketheaspiresstudy‏ ‎‡A Secondary prevention after ischaemic stroke: the ASPIRE-S study‏ ‎‡9 1‏
919 ‎‡a secondarypreventionandcognitivefunctionafterstrokeastudyprotocolfora5yearfollowupoftheaspirescohort‏ ‎‡A Secondary prevention and cognitive function after stroke: a study protocol for a 5-year follow-up of the ASPIRE-S cohort‏ ‎‡9 1‏
919 ‎‡a secondaryresistancetotolvaptanin2patientswithsiadduetosmallcelllungcancer‏ ‎‡A Secondary resistance to tolvaptan in two patients with SIAD due to small cell lung cancer‏ ‎‡9 1‏
919 ‎‡a smokingcessationinpregnancy‏ ‎‡A Smoking cessation in pregnancy‏ ‎‡9 1‏
919 ‎‡a strokerecurrencewithinthetimewindowrecommendedforcarotidendarterectomy‏ ‎‡A Stroke recurrence within the time window recommended for carotid endarterectomy.‏ ‎‡9 1‏
919 ‎‡a strokerehabilitationrecentadvancesandfuturetherapies‏ ‎‡A Stroke rehabilitation: recent advances and future therapies‏ ‎‡9 1‏
919 ‎‡a strokogstrokeandcognitionconsortiumaninternationalconsortiumtoexaminetheepidemiologydiagnosisandtreatmentofneurocognitivedisordersinrelationtocerebrovasculardisease‏ ‎‡A STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease‏ ‎‡9 1‏
919 ‎‡a suboptimallipidmanagementbeforeandafterischaemicstrokeandtiathenorthdublinpopulationstrokestudy‏ ‎‡A Suboptimal lipid management before and after ischaemic stroke and TIA-the North Dublin Population Stroke Study.‏ ‎‡9 1‏
919 ‎‡a developmentoftheprompt‏ ‎‡A The development of the PROMPT‏ ‎‡9 1‏
919 ‎‡a developmentofthepromptprescribingoptimallyinmiddleagedpeoplestreatmentscriteria‏ ‎‡A The development of the PROMPT (PRescribing Optimally in Middle-aged People's Treatments) criteria‏ ‎‡9 1‏
919 ‎‡a effectoftheukincentivebasedcontractonthemanagementofpatientswithcoronaryheartdiseaseinprimarycare‏ ‎‡A The effect of the UK incentive-based contract on the management of patients with coronary heart disease in primary care‏ ‎‡9 1‏
919 ‎‡a renaldysfunctionandchronickidneydiseaseinischemicstrokeandtransientischemicattackapopulationbasedstudy‏ ‎‡A Renal dysfunction and chronic kidney disease in ischemic stroke and transient ischemic attack: A population-based study.‏ ‎‡9 1‏
919 ‎‡a relationshipbetweenarterialstiffnessandstanfordhealthassessmentquestionnairedisabilityinrheumatoidarthritispatientswithoutovertarterialdisease‏ ‎‡A Relationship between arterial stiffness and Stanford Health Assessment Questionnaire disability in rheumatoid arthritis patients without overt arterial disease.‏ ‎‡9 1‏
919 ‎‡a relationshipbetweenarterialdysfunctionandextraarticularfeaturesinpatientswithrheumatoidarthritis‏ ‎‡A Relationship between arterial dysfunction and extra-articular features in patients with rheumatoid arthritis.‏ ‎‡9 1‏
919 ‎‡a ratespredictorsandoutcomesofearlyandlaterecurrenceafterstrokethenorthdublinpopulationstrokestudy‏ ‎‡A Rates, Predictors, and Outcomes of Early and Late Recurrence After Stroke: The North Dublin Population Stroke Study.‏ ‎‡9 1‏
919 ‎‡a ratesanddeterminantsof5yearoutcomesafteratrialfibrillationrelatedstrokeapopulationstudy‏ ‎‡A Rates and Determinants of 5-Year Outcomes After Atrial Fibrillation-Related Stroke: A Population Study.‏ ‎‡9 1‏
919 ‎‡a prescriptionqualityinanacutemedicalward‏ ‎‡A Prescription quality in an acute medical ward‏ ‎‡9 1‏
919 ‎‡a prescribingofantidiabetictherapiesinireland10yeartrends2003‏ ‎‡A Prescribing of antidiabetic therapies in Ireland: 10-year trends 2003-2012.‏ ‎‡9 1‏
919 ‎‡a effectofvitamin500supplementationonarterialstiffnessinanelderlycommunitybasedpopulation‏ ‎‡A The effect of vitamin D supplementation on arterial stiffness in an elderly community-based population‏ ‎‡9 1‏
919 ‎‡a preparednessofnewlyqualifieddoctorsinirelandforprescribinginclinicalpractice‏ ‎‡A Preparedness of newly qualified doctors in Ireland for prescribing in clinical practice.‏ ‎‡9 1‏
919 ‎‡a potentiallyinappropriateprescribingin2populationswithdifferingsocioeconomicprofilesacrosssectionaldatabasestudyusingthepromptcriteria‏ ‎‡A Potentially inappropriate prescribing in two populations with differing socio-economic profiles: a cross-sectional database study using the PROMPT criteria‏ ‎‡9 1‏
919 ‎‡a epidemiologyandtypeofmedicationerrorsreportedtothenationalpoisonsinformationcentreofireland‏ ‎‡A The epidemiology and type of medication errors reported to the National Poisons Information Centre of Ireland‏ ‎‡9 1‏
919 ‎‡a poorreturnoffunctionalmobilityafterhipfractureinolderpatientsitstimetoimproveonhipfractureprevention‏ ‎‡A Poor return of functional mobility after hip fracture in older patients-it's time to improve on hip fracture prevention‏ ‎‡9 1‏
919 ‎‡a pharmacoepidemiologyanirishperspective‏ ‎‡A Pharmacoepidemiology--an Irish perspective‏ ‎‡9 1‏
919 ‎‡a experienceofrecurrentfallersinthe1yearafterstroke‏ ‎‡A The experience of recurrent fallers in the first year after stroke‏ ‎‡9 1‏
919 ‎‡a patientbehaviouratthetimeofstrokeonsetacrosssectionalsurveyofpatientresponsetostrokesymptoms‏ ‎‡A Patient behaviour at the time of stroke onset: a cross-sectional survey of patient response to stroke symptoms‏ ‎‡9 1‏
919 ‎‡a outcomesofendovasculartreatmentforacutelargevesselischaemicstrokemorethan6haftersymptomonset‏ ‎‡A Outcomes of endovascular treatment for acute large-vessel ischaemic stroke more than 6 h after symptom onset.‏ ‎‡9 1‏
919 ‎‡a futureofendovasculartreatmentinsightsfromtheescapeinvestigators‏ ‎‡A The future of endovascular treatment: Insights from the ESCAPE investigators‏ ‎‡9 1‏
919 ‎‡a osteoporosisobesityandsarcopeniaonabdominalctareviewofepidemiologydiagnosticcriteriaandmanagementstrategiesforthereportingradiologist‏ ‎‡A Osteoporosis, obesity, and sarcopenia on abdominal CT: a review of epidemiology, diagnostic criteria, and management strategies for the reporting radiologist‏ ‎‡9 1‏
919 ‎‡a nonequivalenceofinhaledandnebulizedsalbutamolintheassessmentofendothelialdysfunction‏ ‎‡A Nonequivalence of inhaled and nebulized salbutamol in the assessment of endothelial dysfunction.‏ ‎‡9 1‏
919 ‎‡a greatescapeaclinic Alpha rmacologistsjourneyinstrokeresearch‏ ‎‡A The great ESCAPE - a clinical pharmacologist's journey in stroke research.‏ ‎‡9 1‏
919 ‎‡a newinsightsaboutvitamin500andcardiovasculardiseaseanarrativereview‏ ‎‡A New insights about vitamin D and cardiovascular disease: a narrative review‏ ‎‡9 1‏
943 ‎‡a 201x‏ ‎‡A 2012‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 DNB|139651608‏
996 ‎‡2 ISNI|0000000069656754‏
996 ‎‡2 ISNI|0000000041713155‏
996 ‎‡2 LNB|LNC10-000174289‏
996 ‎‡2 NDL|00811478‏
996 ‎‡2 BNC|981058610215906706‏
996 ‎‡2 LC|n 92102720‏
996 ‎‡2 BNF|12415103‏
996 ‎‡2 LC|n 2020182328‏
996 ‎‡2 LC|no2018075878‏
996 ‎‡2 ISNI|0000000043397686‏
996 ‎‡2 ISNI|0000000466939942‏
996 ‎‡2 LC|n 87907973‏
996 ‎‡2 RERO|A003976981‏
996 ‎‡2 LC|nb2011012162‏
996 ‎‡2 NYNYRILM|208909‏
996 ‎‡2 B2Q|0000089416‏
996 ‎‡2 B2Q|0000089414‏
996 ‎‡2 B2Q|0000089415‏
996 ‎‡2 DNB|1143725778‏
996 ‎‡2 LC|no2006019589‏
996 ‎‡2 ISNI|0000000114616226‏
996 ‎‡2 ISNI|0000000080235088‏
996 ‎‡2 NLA|000035609424‏
996 ‎‡2 ISNI|0000000035661408‏
996 ‎‡2 NLA|000035609429‏
996 ‎‡2 LC|no2024046947‏
996 ‎‡2 ISNI|0000000081719754‏
996 ‎‡2 NII|DA06120151‏
996 ‎‡2 LC|no2017076897‏
996 ‎‡2 NLA|000035326489‏
996 ‎‡2 ISNI|0000000514484736‏
996 ‎‡2 BNF|14239284‏
996 ‎‡2 ISNI|0000000040692866‏
996 ‎‡2 LC|no 95030609‏
996 ‎‡2 SUDOC|069674108‏
996 ‎‡2 BNF|12559291‏
996 ‎‡2 LC|n 78075351‏
996 ‎‡2 ISNI|0000000067814755‏
996 ‎‡2 LC|no2003068033‏
996 ‎‡2 LC|no2019066995‏
996 ‎‡2 LC|n 93015369‏
996 ‎‡2 LC|n 00119918‏
996 ‎‡2 ISNI|0000000498986137‏
996 ‎‡2 LC|no2012001262‏
996 ‎‡2 LNB|LNC10-000164615‏
996 ‎‡2 SUDOC|169957705‏
996 ‎‡2 LC|n 78064232‏
996 ‎‡2 DNB|173720072‏
996 ‎‡2 J9U|987007392064305171‏
996 ‎‡2 B2Q|0000118118‏
996 ‎‡2 RERO|A000104456‏
996 ‎‡2 LC|n 80078301‏
996 ‎‡2 NTA|16933824X‏
996 ‎‡2 ISNI|0000000074865841‏
996 ‎‡2 DNB|1261779649‏
996 ‎‡2 ISNI|0000000117766270‏
996 ‎‡2 LC|nb2001056087‏
996 ‎‡2 LC|no 98081699‏
996 ‎‡2 ISNI|0000000070666167‏
996 ‎‡2 LC|n 98090627‏
996 ‎‡2 DNB|1289461716‏
996 ‎‡2 SUDOC|181480123‏
996 ‎‡2 ISNI|0000000040008833‏
996 ‎‡2 NUKAT|n 2020121076‏
996 ‎‡2 LC|no2012138342‏
996 ‎‡2 ISNI|0000000114829934‏
996 ‎‡2 BIBSYS|90384907‏
996 ‎‡2 BNF|17754619‏
996 ‎‡2 LC|n 84002118‏
996 ‎‡2 NII|DA06258512‏
996 ‎‡2 PTBNP|219635‏
996 ‎‡2 J9U|987007463219605171‏
996 ‎‡2 DNB|1190059835‏
996 ‎‡2 CAOONL|ncf10106961‏
996 ‎‡2 RERO|A024135561‏
996 ‎‡2 NII|DA10564793‏
996 ‎‡2 ISNI|0000000140910365‏
996 ‎‡2 ISNI|000000010677657X‏
996 ‎‡2 BNF|13901177‏
996 ‎‡2 LC|n 2023016851‏
996 ‎‡2 DNB|1082104051‏
996 ‎‡2 LC|no2022092335‏
996 ‎‡2 LC|no2007046498‏
996 ‎‡2 J9U|987007335630305171‏
996 ‎‡2 NII|DA0078254X‏
996 ‎‡2 J9U|987007447337105171‏
996 ‎‡2 SUDOC|244949999‏
996 ‎‡2 SUDOC|164479988‏
996 ‎‡2 B2Q|0000095321‏
996 ‎‡2 BIBSYS|90798668‏
996 ‎‡2 ISNI|0000000456939092‏
996 ‎‡2 ISNI|0000000359052131‏
996 ‎‡2 DNB|1242121110‏
996 ‎‡2 ISNI|0000000110839780‏
996 ‎‡2 ISNI|0000000040993458‏
996 ‎‡2 RERO|A005764425‏
996 ‎‡2 LC|n 93072830‏
996 ‎‡2 NUKAT|n 2005104861‏
996 ‎‡2 DNB|122685350‏
996 ‎‡2 DNB|171444663‏
996 ‎‡2 CAOONL|ncf11922699‏
996 ‎‡2 ISNI|0000000096268845‏
996 ‎‡2 LC|no2004110210‏
996 ‎‡2 N6I|vtls002726922‏
996 ‎‡2 LC|n 83145993‏
996 ‎‡2 NUKAT|nx2023695219‏
996 ‎‡2 DNB|1313119253‏
996 ‎‡2 ISNI|000000012018305X‏
996 ‎‡2 NUKAT|n 2007142881‏
996 ‎‡2 LC|no2022115196‏
996 ‎‡2 ISNI|0000000067567715‏
996 ‎‡2 LC|no2003063928‏
996 ‎‡2 LNB|LNC10-000075010‏
996 ‎‡2 ISNI|0000000430527567‏
996 ‎‡2 NUKAT|n 2008051253‏
996 ‎‡2 RERO|A003976972‏
996 ‎‡2 ISNI|0000000398938314‏
996 ‎‡2 RERO|A003976971‏
996 ‎‡2 RERO|A003976976‏
996 ‎‡2 RERO|A003976977‏
996 ‎‡2 RERO|A003976974‏
996 ‎‡2 RERO|A003976975‏
996 ‎‡2 ISNI|0000000066453177‏
996 ‎‡2 RERO|A003976979‏
996 ‎‡2 J9U|987007327408805171‏
996 ‎‡2 DNB|1029487782‏
996 ‎‡2 LC|nb2008011431‏
996 ‎‡2 LC|n 2011035290‏
996 ‎‡2 LC|n 95800036‏
996 ‎‡2 BNC|981058508153406706‏
996 ‎‡2 ISNI|0000000074926587‏
996 ‎‡2 CAOONL|ncf11765258‏
996 ‎‡2 LC|no 93007988‏
996 ‎‡2 ISNI|0000000026728156‏
996 ‎‡2 NDL|00945467‏
996 ‎‡2 SUDOC|235473405‏
996 ‎‡2 LC|no2010197826‏
996 ‎‡2 BNF|12186236‏
996 ‎‡2 BIBSYS|90750103‏
996 ‎‡2 J9U|987007605373305171‏
996 ‎‡2 LC|nb2006024864‏
996 ‎‡2 BNF|17718192‏
996 ‎‡2 CAOONL|ncf11303141‏
996 ‎‡2 LC|n 86032364‏
996 ‎‡2 BIBSYS|9077128‏
996 ‎‡2 BIBSYS|90717366‏
996 ‎‡2 ISNI|0000000116807405‏
996 ‎‡2 NTA|29785724X‏
996 ‎‡2 SUDOC|071471286‏
996 ‎‡2 NII|DA04160370‏
996 ‎‡2 LC|n 93042920‏
996 ‎‡2 NUKAT|n 98701593‏
996 ‎‡2 ISNI|000000003236706X‏
996 ‎‡2 CAOONL|ncf10722749‏
996 ‎‡2 BIBSYS|1542227320947‏
996 ‎‡2 LC|n 95004261‏
996 ‎‡2 CAOONL|ncf11935285‏
996 ‎‡2 ISNI|0000000031652993‏
996 ‎‡2 NUKAT|n 2016180657‏
996 ‎‡2 DNB|126433897X‏
996 ‎‡2 BNF|14010489‏
996 ‎‡2 LC|no2010122863‏
996 ‎‡2 NUKAT|n 2014083914‏
996 ‎‡2 NTA|068544146‏
996 ‎‡2 DNB|1130877604‏
996 ‎‡2 DNB|140705244‏
996 ‎‡2 LC|no2019012245‏
996 ‎‡2 SUDOC|032172753‏
996 ‎‡2 NKC|ntk2015854831‏
996 ‎‡2 RERO|A013758266‏
996 ‎‡2 ISNI|0000000038692760‏
996 ‎‡2 SUDOC|116438827‏
996 ‎‡2 NUKAT|n 99040121‏
996 ‎‡2 NTA|198013841‏
996 ‎‡2 CAOONL|ncf10051019‏
996 ‎‡2 NTA|370365828‏
996 ‎‡2 BNF|12276438‏
996 ‎‡2 BNF|14502956‏
996 ‎‡2 ISNI|0000000439813930‏
996 ‎‡2 NTA|069100098‏
996 ‎‡2 LC|no2006115565‏
996 ‎‡2 J9U|987007429913605171‏
996 ‎‡2 BNF|12358994‏
996 ‎‡2 J9U|987007262338205171‏
996 ‎‡2 LC|n 86121810‏
996 ‎‡2 ISNI|0000000044827107‏
996 ‎‡2 LC|nb2003047091‏
996 ‎‡2 RERO|A023862149‏
996 ‎‡2 NLA|000035685817‏
996 ‎‡2 SUDOC|149294336‏
996 ‎‡2 NKC|xx0204832‏
996 ‎‡2 CAOONL|ncf10372946‏
996 ‎‡2 LC|n 00087596‏
996 ‎‡2 BNF|14519673‏
996 ‎‡2 BNF|12358848‏
996 ‎‡2 LC|n 88611239‏
996 ‎‡2 J9U|987007334704605171‏
996 ‎‡2 DNB|135851661‏
996 ‎‡2 NKC|ntk2014850117‏
996 ‎‡2 ISNI|0000000033664293‏
996 ‎‡2 LC|no 93015706‏
996 ‎‡2 LC|n 87885335‏
996 ‎‡2 NTA|127477837‏
996 ‎‡2 DNB|170360946‏
996 ‎‡2 ISNI|0000000367660583‏
996 ‎‡2 BNF|12378003‏
996 ‎‡2 LIH|LNB:CZKJ;=BO‏
996 ‎‡2 ISNI|0000000073888099‏
996 ‎‡2 ISNI|0000000495870227‏
996 ‎‡2 SUDOC|119458039‏
996 ‎‡2 NUKAT|n 2014093525‏
996 ‎‡2 BIBSYS|2000346‏
996 ‎‡2 RERO|A010231065‏
996 ‎‡2 SUDOC|255586795‏
996 ‎‡2 ISNI|0000000073998861‏
996 ‎‡2 NTA|133098559‏
996 ‎‡2 JPG|500081243‏
996 ‎‡2 ISNI|0000000406893022‏
996 ‎‡2 NTA|355347296‏
996 ‎‡2 DNB|1145716229‏
996 ‎‡2 NTA|075032112‏
996 ‎‡2 ISNI|000000007102529X‏
996 ‎‡2 NTA|329284010‏
996 ‎‡2 BNF|15054922‏
996 ‎‡2 DNB|1143633660‏
996 ‎‡2 LC|nb2017021500‏
996 ‎‡2 NUKAT|n 2008056702‏
996 ‎‡2 ISNI|0000000035690268‏
996 ‎‡2 NII|DA00579353‏
996 ‎‡2 BNF|16963124‏
996 ‎‡2 ISNI|0000000389252732‏
996 ‎‡2 ISNI|0000000498138648‏
996 ‎‡2 J9U|987007326174705171‏
996 ‎‡2 NII|DA08190293‏
996 ‎‡2 RERO|A008842296‏
996 ‎‡2 NTA|126257167‏
996 ‎‡2 LC|n 84219986‏
996 ‎‡2 LC|nb2005002029‏
996 ‎‡2 BIBSYS|90504501‏
996 ‎‡2 J9U|987007383701805171‏
996 ‎‡2 BNF|16728254‏
996 ‎‡2 NTA|068904657‏
996 ‎‡2 LC|nb 98033149‏
996 ‎‡2 J9U|987007463219805171‏
996 ‎‡2 J9U|987007437583005171‏
996 ‎‡2 LC|no2009175179‏
996 ‎‡2 DNB|1143635388‏
996 ‎‡2 ISNI|0000000054980797‏
996 ‎‡2 DNB|1152416766‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏